Regional Gene Therapy Consultant - Upper Midwest (IL/WI/MN)
Cette offre est-elle pour vous ?
Créer mon CV Créez votre CV et découvrez votre pourcentage de correspondance avec ce poste — et avec tous les autres.
Suivez vos candidatures sur mobile L'application Whileresume, gratuite, sur iPhone et Android.
Le poste
The Regional Gene Therapy Consultant will drive the commercial launch of Vyjuvek for DEB in Wisconsin, Minnesota, and Illinois with a patient-first focus.
Build and execute a territory business plan to identify patient opportunities and promote Vyjuvek to pediatric dermatologists and other DEB care providers.
Educate healthcare professionals on indication, safety, and efficacy through meetings, presentations, and other educational formats.
Collaborate with patient services, field reimbursement, and cross-functional partners to ensure site-of-care access and successful administration.
Manage CRM data, track territory performance, and responsibly allocate IOE budgets and promotional materials.
Travel as needed, develop KOL relationships, and execute local speaker programs and sponsorships to foster brand adoption.
Build and execute a territory business plan to identify patient opportunities and promote Vyjuvek to pediatric dermatologists and other DEB care providers.
Educate healthcare professionals on indication, safety, and efficacy through meetings, presentations, and other educational formats.
Collaborate with patient services, field reimbursement, and cross-functional partners to ensure site-of-care access and successful administration.
Manage CRM data, track territory performance, and responsibly allocate IOE budgets and promotional materials.
Travel as needed, develop KOL relationships, and execute local speaker programs and sponsorships to foster brand adoption.
Voir l'offre en entier
Missions, profil recherché, compétences et avantages — en créant votre compte gratuitement.
ou
Déjà un compte ?
Se connecterCes offres pourraient vous intéresser
Aucune offre vraiment proche pour l'instant — voici les plus récentes.